Meet our Board

At The Eve Appeal we have a passionate and committed Board of Trustees who want to make a real difference to the women and their family and friends affected by gynaecological cancer.

Find out below, why each member of the Board of Trustees joined The Eve Appeal.


Melanie Richards - Chair of Trustees

Melanie was until September 2020 the Deputy Chair of KPMG UK, with a period as Acting Chair during the pandemic. Melanie was awarded a CBE for her contribution to business and to the diversity and inclusion agenda in 2019. She is a founding member of the 30% Club Steering Committee, sits on the Steering Group of the FTSE Women Leader’s Review and won the Outstanding Contribution to Social Mobility Award in 2018.

“I am very proud to support the vital work of the Eve Appeal.  Having seen a friend diagnosed and treated for ovarian cancer, it has made me acutely aware of the impact this and other gynaecological cancers have on women and their families. Happily she survived but there are many who are not so lucky and for whom diagnosis comes too late. The Eve Appeal funds ground-breaking research which I am confident will improve the chances and lives of women throughout the world.”


Judy Bloomer – Trustee

Judy is a former teacher and psychotherapist who has been involved with a range of charity committees and Trustee roles.

“I had a personal connection with the cause as my Grandmother and a close friend had sadly died of ovarian cancer. Due to family issues, I became much more passionate and became involved in the charity’s clay shoot – when I was mistakenly diagnosed with ovarian cancer too. I was then delighted when I jointed The Eve Appeal as a Trustee.”


Jenny Leonard – Trustee

Jenny is a solicitor by profession, working at the Metropolitan Police Service as Assistant Director of the Directorate of Legal Services – but she became involved with The Eve Appeal for personal reasons.

“In 2003, I was diagnosed with ovarian cancer, which was quite traumatic for me as I was only in my 30’s at the time. However, I was fortunate that it was diagnosed at an early stage – 1C. I became interested in a range of ovarian cancer charities through research about the condition and wanted to do something more charitable – and that’s why I am now a Trustee for the charity.”

Ian Drew - Trustee

Ian is a Global Business Leader with over 25 years of experience of global leadership in the technology industry. He also has extensive experience within marketing, business development, strategy, investment, mergers & acquisitions and sales experience in large FTSE and NASDAQ Companies.

In addition, Ian has founded a number of start-ups in the security and open-source industries.


Sidonie Kingsmill - Trustee

Sidonie is a Brand and Marketing expert with 20 years’ experience having held many senior roles at companies such as Procter & Gamble, Nestle Purina Petcare, Metro Newspaper and most recently Tesco.

In her role as Group Brands Director at Tesco, Sidonie completely overhauled Tesco’s approach to Private Label (called Own Brands), resulting in a turnaround of all Own Brands to growth in first two years, the creation of eight new brands in the following two years, and the redevelopment of all the existing brands over seven years. In total, delivering approximately £100m additional sales.

Sarah Clarke's headshot

Sarah Clark - Trustee

Sarah is an international digital executive with expertise across developed and developing markets. She has broad international commercial experience in a variety of industries including travel, retail, financial services, fintech and e-commerce in markets spanning Europe, the USA, and the Middle East and Africa.

My sister was diagnosed with cervical cancer when she was a single mother to 2.5 year old twins. She thankfully survived, but I want to ensure that women are given the best possible chance for survival of gynaecological cancers. Nurturing ground-breaking detection tools through The Eve Appeal is a great opportunity to do that.

Cathy Pittham Wiley - Trustee

Cathy Pittham Wiley is an NED and business adviser following a 28 year career in the world of communications and advertising. She has worked for large international groups such as Interpublic and WPP at an international level, on award-winning digital campaigns for countries and companies – specialising in the technology and med tech sectors. She is a cancer survivor.

My involvement with The Eve Appeal dates back over ten years to when I lost a friend to ovarian cancer. Following my own experience and hers, I realised how urgent it is that we educate women better about their bodies and symptoms to watch out for. Not only that, but how vital early detection is in successfully treating the five types of gynae cancers. The Eve Appeal is unique in its mission to deliver on both of those goals and we all feel passionately about our aims to prevent women suffering the tragedy – all too common –  of late diagnoses and to fund research that identifies the best ways to detect these invisible cancers in the earliest stages.

Sarah Morris - Trustee

Sarah is an experienced leader with significant international experience gained across multiple sectors, industries, countries and cultures. Most recently Sarah was Group Chief People Officer of Aviva plc. She is a member of the Global 30% Club steering committee, and of HRH Countess of Wessex Women’s Network Forum Board. Prior to Aviva, Sarah held Executive roles in the US at data and technology specialists, Thomson Reuters, BP plc oil and gas, RSA insurance and Dixons Carphone retailing.

Sarah has a passionate interest in this all the work that The Eve Appeal does having benefitted herself from the pioneering surgical research in this area.

Lay Koon Tan- Trustee

During her 15 years at Arthur Andersen, the last four as a Partner, Lay Koon consulted a wide range of financial institutions including FTSE 100 companies, stock exchanges and central banks in the UK and abroad.

In 2000 she founded Nature Squared: an ethical business, grounded on the principles of sustainability, leveraging heritage craft skills to transform waste natural materials into luxury surfaces for a wide range of applications, from mega yachts interiors to luxury pens or unique art pieces.Embodying Lay Koon’s original values and ambitions, Nature Squared today employs a 200 strong workforce of artisans, engineers, materiologists and project managers, a large part of whom are based in the Philippines.

Dr Christine Ekechi- Trustee

Dr Ekechi is a Consultant Obstetrician & Gynaecologist at Queen Charlotte’s & Chelsea Hospital, Imperial College Healthcare NHS Trust in London, and is also a women’s health educator and advocate. Her interest is in the gender and racial disparities continually present within the health system today.

She is the Co-Chair of the Race Equality Taskforce at the Royal College of Obstetricians & Gynaecologists and also their spokesperson for racial equality, she is also the RCOG Clinical Champion for The Women’s Network. 

Dr Ekechi holds a Masters in Reproductive Health Research from the London School of Hygiene and Tropical Medicine and her previous public health experience includes working with the UN, UNICEF, and national governments in the UK, Nigeria, Senegal, Malawi and Kenya.

Tamara Box- Trustee

Tamara Box is the Managing Partner, EME and a member of the global board at Reed Smith LLP.

Tamara is a founding member of the Steering Committee of the 30% Club, an influential group seeking to enlist Chairs and CEOs to bring more women into senior management and onto boards.

Tamara is also a member of the Board of Interpath Advisory, a member of the Board of the Chartered Management Institute, a trustee of gynaecological cancer charity The Eve Appeal, a member of the Advisory Board of children’s charity, Theirworld and a member of the Court of Governors of the London School of Economics.  Finally, Tamara has been included in the Global Yahoo Finance HERoes Women Role Model List every year since its inception.

Dr Adam Rosenthal BSc (hons) MB BS PhD FRCOG

Adam is a Consultant Gynaecologist at UCLH where he leads the cervical screening and gynae cancer prevention surgery programs. He is also an Honorary Associate Clinical Professor at UCL.

He has an international reputation in this field, having been the clinical lead on the world’s largest screening trial of women at high risk of ovarian cancer (UKFOCSS trial), and he currently leads the NHS pilot ovarian cancer screening program for women with BRCA1 and BRCA2 gene mutations (the ALDO Project). He also sits on Public Health England’s Cervical Cancer Screening Research Advisory Committee.

Adam has a long association with The Eve Appeal as one of the charity’s key medical advisors and is a passionate advocate for the optimal care of women at increased risk of gynaecological cancer.